388 related articles for article (PubMed ID: 20363024)
21. Ferrocene tripeptide Gly-Pro-Arg conjugates: synthesis and inhibitory effects on Alzheimer's Aβ(1-42) fibrillogenesis and Aβ-induced cytotoxicity in vitro.
Zhou B; Li CL; Hao YQ; Johnny MC; Liu YN; Li J
Bioorg Med Chem; 2013 Jan; 21(2):395-402. PubMed ID: 23245572
[TBL] [Abstract][Full Text] [Related]
22. The binding of apolipoprotein E to oligomers and fibrils of amyloid-β alters the kinetics of amyloid aggregation.
Garai K; Verghese PB; Baban B; Holtzman DM; Frieden C
Biochemistry; 2014 Oct; 53(40):6323-31. PubMed ID: 25207746
[TBL] [Abstract][Full Text] [Related]
23. Direct evidence for self-propagation of different amyloid-β fibril conformations.
Spirig T; Ovchinnikova O; Vagt T; Glockshuber R
Neurodegener Dis; 2014; 14(3):151-9. PubMed ID: 25300967
[TBL] [Abstract][Full Text] [Related]
24. In vitro antiaggregation and deaggregation potential of Rhizophora mucronata and its bioactive compound (+)- catechin against Alzheimer's beta amyloid peptide (25-35).
Suganthy N; Sheeja Malar D; Pandima Devi K
Neurol Res; 2016 Dec; 38(12):1041-1051. PubMed ID: 27766923
[TBL] [Abstract][Full Text] [Related]
25. Chemical cross-linking/mass spectrometry maps the amyloid β peptide binding region on both apolipoprotein E domains.
Deroo S; Stengel F; Mohammadi A; Henry N; Hubin E; Krammer EM; Aebersold R; Raussens V
ACS Chem Biol; 2015 Apr; 10(4):1010-6. PubMed ID: 25546376
[TBL] [Abstract][Full Text] [Related]
26. Alzheimer's amyloid-β A2T variant and its N-terminal peptides inhibit amyloid-β fibrillization and rescue the induced cytotoxicity.
Lin TW; Chang CF; Chang YJ; Liao YH; Yu HM; Chen YR
PLoS One; 2017; 12(3):e0174561. PubMed ID: 28362827
[TBL] [Abstract][Full Text] [Related]
27. Ferulic acid inhibits the transition of amyloid-β42 monomers to oligomers but accelerates the transition from oligomers to fibrils.
Cui L; Zhang Y; Cao H; Wang Y; Teng T; Ma G; Li Y; Li K; Zhang Y
J Alzheimers Dis; 2013; 37(1):19-28. PubMed ID: 23727899
[TBL] [Abstract][Full Text] [Related]
28. The Osaka FAD mutation E22Δ leads to the formation of a previously unknown type of amyloid β fibrils and modulates Aβ neurotoxicity.
Ovchinnikova OY; Finder VH; Vodopivec I; Nitsch RM; Glockshuber R
J Mol Biol; 2011 May; 408(4):780-91. PubMed ID: 21402079
[TBL] [Abstract][Full Text] [Related]
29. Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides.
Tokuda T; Calero M; Matsubara E; Vidal R; Kumar A; Permanne B; Zlokovic B; Smith JD; Ladu MJ; Rostagno A; Frangione B; Ghiso J
Biochem J; 2000 Jun; 348 Pt 2(Pt 2):359-65. PubMed ID: 10816430
[TBL] [Abstract][Full Text] [Related]
30. Laminin inhibits both Abeta40 and Abeta42 fibril formation but does not affect Abeta40 or Abeta42-induced cytotoxicity in PC12 cells.
Monji A; Tashiro K; Yoshida I; Kaname H; Hayashi Y; Matsuda K; Tashiro N
Neurosci Lett; 1999 May; 266(2):85-8. PubMed ID: 10353333
[TBL] [Abstract][Full Text] [Related]
31. ApoE-fragment/Aβ heteromers in the brain of patients with Alzheimer's disease.
Mouchard A; Boutonnet MC; Mazzocco C; Biendon N; Macrez N;
Sci Rep; 2019 Mar; 9(1):3989. PubMed ID: 30850702
[TBL] [Abstract][Full Text] [Related]
32. Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E.
Castano EM; Prelli F; Wisniewski T; Golabek A; Kumar RA; Soto C; Frangione B
Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):599-604. PubMed ID: 7534068
[TBL] [Abstract][Full Text] [Related]
33. Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity.
Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; de Waal RM; Verbeek MM
Brain Res; 2006 May; 1089(1):67-78. PubMed ID: 16635482
[TBL] [Abstract][Full Text] [Related]
34. Bioactive polyphenol interactions with β amyloid: a comparison of binding modelling, effects on fibril and aggregate formation and neuroprotective capacity.
Das S; Stark L; Musgrave IF; Pukala T; Smid SD
Food Funct; 2016 Feb; 7(2):1138-46. PubMed ID: 26815043
[TBL] [Abstract][Full Text] [Related]
35. ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-beta1-42.
Trommer BL; Shah C; Yun SH; Gamkrelidze G; Pasternak ES; Stine WB; Manelli A; Sullivan P; Pasternak JF; LaDu MJ
Neurobiol Dis; 2005 Feb; 18(1):75-82. PubMed ID: 15649697
[TBL] [Abstract][Full Text] [Related]
36. Chitosan Oligosaccharides Inhibit/Disaggregate Fibrils and Attenuate Amyloid β-Mediated Neurotoxicity.
Dai X; Hou W; Sun Y; Gao Z; Zhu S; Jiang Z
Int J Mol Sci; 2015 May; 16(5):10526-36. PubMed ID: 26006224
[TBL] [Abstract][Full Text] [Related]
37. Fluorescence resonance energy transfer analysis of apolipoprotein E C-terminal domain and amyloid beta peptide (1-42) interaction.
Phu MJ; Hawbecker SK; Narayanaswami V
J Neurosci Res; 2005 Jun; 80(6):877-86. PubMed ID: 15880461
[TBL] [Abstract][Full Text] [Related]
38. The potential inhibitory effect of β-casein on the aggregation and deposition of Aβ
Hojati S; Ghahghaei A; Lagzian M
J Biomol Struct Dyn; 2018 Jun; 36(8):2118-2130. PubMed ID: 28633568
[TBL] [Abstract][Full Text] [Related]
39. Anthocyanin suppresses the toxicity of Aβ deposits through diversion of molecular forms in in vitro and in vivo models of Alzheimer's disease.
Yamakawa MY; Uchino K; Watanabe Y; Adachi T; Nakanishi M; Ichino H; Hongo K; Mizobata T; Kobayashi S; Nakashima K; Kawata Y
Nutr Neurosci; 2016; 19(1):32-42. PubMed ID: 26304685
[TBL] [Abstract][Full Text] [Related]
40. The Effects of N-terminal Mutations on β-amyloid Peptide Aggregation and Toxicity.
Foroutanpay BV; Kumar J; Kang SG; Danaei N; Westaway D; Sim VL; Kar S
Neuroscience; 2018 May; 379():177-188. PubMed ID: 29572166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
